AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Glycemo 15mg Tablet SR

Prescription Icon
Prescription Required

Marketer

Ark Life Sciences Pvt Ltd

Salt Composition

Pioglitazone (15mg)

Overview Glycemo 15mg Tablet SR

Diabetace 15mg Extended-Release Tablets are prescribed for adult patients with type 2 diabetes to manage blood glucose. This medication aids in regulating blood sugar, thereby reducing the risk of severe diabetic complications such as vision impairment and nephropathy. Diabetace 15mg ER Tablets can be administered alone or in conjunction with other medications, with or without food. Consistent daily dosing at the same time maximizes therapeutic efficacy. Dosage adjustments may be made by your physician based on treatment response. Continued use is crucial, even with well-controlled blood sugar, as abrupt cessation can lead to elevated glucose levels and potentially serious consequences, including neuropathy, limb loss, visual disturbances, and kidney damage. Remember, this medication is one component of a comprehensive diabetes management plan, encompassing a doctor-recommended diet, regular physical activity, and weight management; lifestyle choices are paramount in diabetes control. Commonly reported side effects include headache, sore throat, muscle aches, and sinus inflammation. Persistent or bothersome side effects warrant immediate medical attention. This medication is contraindicated in patients with type 1 diabetes, diabetic ketoacidosis, or severe hepatic or renal impairment. Prior to commencing treatment, inform your doctor of any pre-existing heart, thyroid, or endocrine disorders, as Diabetace 15mg ER Tablets may not be appropriate in all cases. Pregnant or lactating women should seek medical counsel before using this medication. Regular blood glucose monitoring is essential, along with periodic blood tests to assess blood cell counts and liver function as directed by your physician.

Uses of Glycemo 15mg Tablet SR

Managing type 2 diabetes

Major Benefits of Glycemo 15mg Tablet SR:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and timeframe. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Glycemo 15mg Extended-Release Tablets can be administered with or without food, although consistent timing is recommended.

Common Side effects of Glycemo 15mg Tablet SR:

  • Headache
  • Sore throat
  • Sinus inflammation
  • Muscle pain

How to use Glycemo 15mg Tablet SR:

Follow your doctor's instructions precisely regarding dosage and treatment length for Glycemo 15mg Tablet SR. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. This medication can be administered with or without food, although consistent timing is recommended.

How Glycemo 15mg Tablet SR works:

Glycemo SR 15mg tablets are used to treat diabetes. Their mechanism of action involves enhancing insulin responsiveness, thereby regulating blood glucose.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent alcohol consumption and Glycemo 15mg Tablet SR is contraindicated.

PregnancyPregnancyCONSULT YOUR DOCTOR

Extended-release Glycemo 15mg tablets may pose risks during pregnancy. While human data is scarce, animal research indicates potential harm to the unborn. A physician will assess the advantages against possible hazards prior to prescribing. Seek medical advice.

Breast feedingBreast feedingCAUTION

Extended-release Glycemo 15mg tablets require careful consideration during lactation. Breastfeeding should be temporarily discontinued until maternal treatment concludes and the medication is fully cleared from the mother's system. Close monitoring of the infant's blood glucose levels is necessary while the mother is taking Glycemo 15mg SR tablets.

DrivingDrivingSAFE

Driving ability is typically unaffected by Glycemo 15mg sustained-release tablets.

KidneyKidneySAFE IF PRESCRIBED

Extended-release Glycemo 15mg tablets are considered safe for use in individuals with renal impairment. No alteration of the Glycemo 15mg extended-release tablet dosage is advised.

LiverLiverCAUTION

Patients with liver impairment should exercise caution when using Glycemo 15mg SR tablets; dosage modification may be necessary. Consult a physician for guidance. Glycemo 15mg SR tablets are contraindicated in patients exhibiting severe hepatic dysfunction.

What if you forget to take Glycemo 15mg Tablet SR :

Omit any missed Glycemo 15mg Tablet SR dose and resume your usual medication regimen. Avoid taking a double dose.

Facts to Know About Glycemo 15mg Tablet SR

LabelValue
Pharmaceutical Category TZD-class medication
Potential for Dependence None.
Type of Medication Medication for diabetes
Mechanism of Action PPAR gamma activator (TZD)

FAQs on Glycemo 15mg Tablet SR

Glycemo 15mg sustained-release tablets are frequently associated with weight increase, potentially linked to dosage. This weight gain may result from fat deposition; however, in individuals with heart failure, fluid retention may be the contributing factor. Consequently, close monitoring of weight is crucial for patients with heart failure.
Extended-release Glycemo 15mg tablets can lead to fluid buildup, potentially worsening or accelerating pre-existing heart failure. For individuals with one or more heart failure risk factors (such as prior myocardial infarction, coronary artery disease, or advanced age), physicians typically initiate treatment with the minimum effective dose, progressively increasing it as tolerated. Concomitant use of Glycemo 15mg tablets and insulin increases the likelihood of heart failure.
Glycemo 15mg Extended-Release Tablets may be added to metformin therapy in adult patients with type 2 diabetes when metformin alone proves insufficient to manage blood glucose levels effectively. This combination is suitable for adults with type 2 diabetes and those who are overweight and experiencing inadequate glycemic control.
This medication is typically administered once daily, at any time of day, though consistent daily timing is recommended. It may be taken with or without food. Always follow your physician's instructions precisely when using Glycemo 15mg Tablet SR.
Maintain Glycemo 15mg Tablet SR use as directed by your physician. Diabetes mellitus management is ongoing, potentially requiring lifelong medication. Discontinuation should only occur following consultation with your doctor, who can provide alternative treatment options. Ceasing treatment without medical guidance may elevate blood glucose, posing health risks.
Elevated liver enzyme levels are a potential side effect of Glycemo 15mg Tablet SR; discontinue Glycemo 15mg Tablet SR if this occurs. Regular monitoring of liver enzyme levels is therefore necessary during treatment. Patients with pre-existing liver conditions should not receive Glycemo 15mg Tablet SR.
Glycemo 15mg Sustained-Release tablets are classified as thiazolidinediones, a group of medications used to treat diabetes. These tablets regulate blood glucose by enhancing the body's utilization of insulin. This effect is achieved through increased cellular responsiveness to the insulin produced naturally by the body.
Extended-release Glycemo 15mg tablets may be associated with a very low risk of bladder cancer. Seek immediate medical attention if you develop hematuria, dysuria, or urinary urgency while taking this medication. Patients with a history of bladder cancer should not use Glycemo 15mg Tablet SR.
Glycemo 15mg Tablet SR
53
MRP 65
18% off